Rui Lisheng (romiplostim biosimilar)

ITJ(QN)2510: A Multicenter Clinical Study of Romiplostim N01 in the Treatment of Sepsis-related Thrombocytopenia (clinicaltrials.gov)

N01-A-PICIT-GT: Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid Tumors (clinicaltrials.gov)

N01-A-PICIT-GI: Romiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gastrointestinal Solid Tumors (clinicaltrials.gov)

Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients (clinicaltrials.gov)

A Single-center, Prospective, Single-arm Observational Study of Romiplostim N01 Combined with Standard Immunosuppressive Therapy in Patients with Aplastic Anemia (AA) (ChiCTR2600120617)

Phase II Study of Romiplostim N01 for Cancer Treatment-Induced Thrombocytopenia in Hematologic Malignancies: A Prospective, Single-Arm Trial (ChiCTR2600117997)

A Study on the Treatment of CTIT of the Efficacy and Safety With Romiplostim N01 Compared to Recombinant Human Interleukin-11 (clinicaltrials.gov)

Safety and Efficacy Study of QL0911 to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients (clinicaltrials.gov)

QL0911-102: A Phase 1, Randomized, Double-Blind, Two-Arm, Two-Way Crossover Study of Pharmacokinetics and Pharmacodynamics of QL0911 (2025-523355-59-00)

Single-center clinical study on the efficacy and safety of romiplostim N01 in promoting platelet engraftment after hematopoietic stem cell transplantation (ChiCTR2600116939)

A Single-Arm, Multicenter, Exploratory Study on the Efficacy and Safety of Romiplostim NO1 in Platelet Recovery After Autologous Hematopoietic Stem Cell Transplantation (ChiCTR2500114483)

A Multicenter, Single-Arm Study of Romiplostim N01 in Megakaryocytic Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Bone Marrow Failure Diseases (ChiCTR2600116641)